<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Hepatitis C viral life cycle
2
Hepatitis C virus
3
Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents
4
Hepatitis C Virus (HCV) “A Possible Independent Risk Factor” for Coronary Artery Disease
5
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells
6
Hepatitis C virus (HCV) genotype 1B infection is associated with a high incidence of graft cirrhosis after liver transplantation (OLT)
7
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
8
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection
9
Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan
10
Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction
11
Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital
12
Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection
13
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia
14
Hepatitis C virus (HCV)-infection and oral lichen planus
15
Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
16
Hepatitis C virus and blood transfusion: past and present risks
17
Hepatitis C virus and hepatocellular carcinoma
18
Hepatitis c virus and human immunodeficiency virus: clinical issues in coinfection
19
Hepatitis C Virus and Human Immunodeficiency Virus-I (HIV) Co-Infection in Children in Benin City, Nigeria.
20
Hepatitis C virus and kidney disease
21
Hepatitis C Virus and Lichen Planus: The Real Association
22
Hepatitis C virus and liver steatosis: when fat is not beautiful
23
Hepatitis C Virus and Vaccine Development
24
Hepatitis C Virus Antibodies and Vitiligo Disease
25
Hepatitis C Virus Antibody Positive Cases in Multitransfused Thalassemic Patients in South of Iran
26
Hepatitis C virus antibody, viral RNA and genotypes in leprous patients in Japan
27
Hepatitis C Virus as a Multifaceted Disease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection
28
Hepatitis C virus assembly: When fat makes it easier
29
Hepatitis C Virus Capsid Protein and Intracellular Lipids Interplay and Its Association With Hepatic Steatosis
30
Hepatitis C virus challenges AIDS associated viruses at the transfusion crossings: the place and time for a second trial
31
Hepatitis C virus clearance improves quality of life
32
Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin
33
Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals
34
Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b
35
Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression
36
Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes
37
Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
38
Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation
39
Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation
40
Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2
41
Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation
42
Hepatitis C Virus Core Protein: An Update on Its Molecular Biology, Cellular Functions and Clinical Implications
43
Hepatitis C Virus Cryoglobulinemia and non-Hodgkin Lymphoma
44
Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients
45
Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein
46
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
47
Hepatitis C virus genetic variability in patients undergoing antiviral therapy
48
Hepatitis C virus genotype 1 associated with massive steatosis of the liver and hypo-β-lipoproteinemia
49
Hepatitis C Virus Genotype Distribution in Shiraz, Southern Iran
50
Hepatitis C Virus Genotypes and Association With Viral Load in Yazd, Central Province of Iran
51
Hepatitis C virus genotypes and quasispecies
52
Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia
53
HEPATITIS C VIRUS GENOTYPES IN A NORTHEASTERN AREA OF BRAZIL
54
Hepatitis C virus genotypes in Adana and Antakya regions of Turkey
55
HEPATITIS C VIRUS GENOTYPES IN BAHAWALPUR
56
Hepatitis C virus genotypes in elderly patients with chronic hepatitis C
57
HEPATITIS C VIRUS GENOTYPES IN IRAQ
58
Hepatitis C Virus Genotypes in Patients Referred to Educational Hospitals in Zahedan (2009 ‒ 2013)
59
Hepatitis C virus Genotypes in Patients with End-Stage Renal Disease in East Azerbaijan, Iran
60
Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples
61
Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azerbaijan, Northwest of Iran
62
Hepatitis C virus in blood donation
63
Hepatitis C virus in breast milk
64
Hepatitis C virus in elderly patients with chronic liver diseases
65
HEPATITIS C VIRUS IN IRAN: EPIDEMIOLOGY OF AN EMERGING INFECTION
66
Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes
67
Hepatitis C Virus in North Africa: An Emerging Threat
68
Hepatitis C virus in people with HIV infection
69
Hepatitis C virus in people with HIV infection
70
Hepatitis C virus in saliva of haemophiliac patients attending an oral surgery unit
71
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
72
Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy
73
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk
74
Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran
75
Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt
76
Hepatitis C virus infection among patients on hemodialysis: A report from a single center in Iran
77
Hepatitis C Virus Infection among Teaching Hospital Patients in Kano, Nigeria: A Retrospective Study
78
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town
79
Hepatitis C virus infection and autoimmune thrombocytopenic purpura
80
Hepatitis C Virus Infection and Chronic Obstructive Pulmonary Disease
81
Hepatitis C virus infection and cryoglobulinemia
82
Hepatitis C virus infection and genotypes in blood donors
83
Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
84
Hepatitis C Virus Infection and Kidney Transplantation A Review for Clinicians
85
Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France
86
Hepatitis C virus infection and primary Sjögrenʹs Syndrome: A clinical and serologic description of 9 patients
87
Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt
88
Hepatitis C Virus Infection Complicated by Kidney Disease
89
Hepatitis C Virus Infection in Blood Donors: An Emerging Risk to Transfusion Services
90
Hepatitis C virus infection in children
91
Hepatitis C virus infection in dialysis centers of Tabriz, Iran: a multicenter study
92
Hepatitis C virus infection in dialysis patients
93
Hepatitis C virus infection in Eastern Europe
94
Hepatitis C virus infection in hemodialysis patients in Sudan: Two centers report
95
Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures
96
Hepatitis C Virus Infection in Isfahan, Iran: A Review Article
97
Hepatitis C virus infection in nephrology patients
98
Hepatitis C Virus Infection in Non-Hodgkin’s Lymphoma: A Case-ControlStudy
99
HEPATITIS C VIRUS INFECTION IN PATIENTS ON LONG TERM HEMODIALYSIS
100
Hepatitis C Virus Infection in Patients with Hemophilia in Isfahan, Iran
101
Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication
102
Hepatitis C virus infection in special groups
103
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis
104
Hepatitis C virus infection in the United States
105
Hepatitis C virus infection in Western Europe
106
Hepatitis C virus infection manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis
107
Hepatitis C virus infection of salivary gland epithelial cells : Lack of evidence
108
Hepatitis C Virus Infection Trends in Italy
109
Hepatitis C Virus Infection Trends in Italy, 1996–2006
110
Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction
111
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?
112
Hepatitis C virus infection, tuberculosis, and sexually transmitted diseases
113
Hepatitis C virus infection: co-infection with HIV and HBV
114
Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in I.R. IRAN
115
Hepatitis C virus infection: quality of life and side effects of treatment
116
Hepatitis C virus infection: when silence is deception
117
Hepatitis C virus infection-associated non-cryoglobulinaemic monoclonal IgMκ gammopathy responsive to interferon-α treatment
118
Hepatitis C Virus Load in Seropositive Liver and Kidney Transplant Recipients by Quantitative Real-Time PCR Before and After Transplantation
119
Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture
120
Hepatitis C virus NS3 NTPase/Helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step
121
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety Original Research Article
122
Hepatitis C Virus NS3 Protease Requires Its NS4A Cofactor Peptide for Optimal Binding of a Boronic Acid Inhibitor as Shown by NMR Original Research Article
123
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding
124
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of moiety with improved potency
125
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034
126
Hepatitis C virus NS3-4A serine protease inhibitors: Use of a P2–P1 cyclopropyl alanine combination for improved potency
127
Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death
128
Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt
129
Hepatitis C Virus RNA (HCV-RNA) in Blood Donors and Family Members Seropositive for Anti-HCV Antibodies
130
Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L
131
Hepatitis C virus RNAs replicating in cell culture
132
Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department
133
Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity
134
Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran
135
Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine
136
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
137
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
138
Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA
139
Hepatitis C virus transmission by intravenous immunoglobulin
140
Hepatitis C virus transmission by monoclonal- purified viral-attenuated factor VIII concentrate
141
Hepatitis C Virus Treatment Revolution: Eastern European Story
142
Hepatitis C Virus Treatment with Sofosbuvir Plus Ribavirin Regimen in Khuzestan Province
143
Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes
144
Hepatitis C virus ultrastructure and morphogenesis.
145
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients
146
Hepatitis C virus, rheumatoid factors, and disease progression
147
Hepatitis C virus, Sjögrenʹs syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer
148
Hepatitis C Virus. Current Studies in Hematology and Blood Transfusion : Edited by Harvey Reesink, 212, S. Karger AG, Basel, DM 290, ISBN 3-8055-5866-X
149
Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, November 2011, Tehran, Iran
150
Hepatitis C Virus; Its Implication for Endodontists
151
Hepatitis C virus-related arthritis
152
Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C
153
Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy
154
Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level in Healthy, Anti-HCV-Negative Individuals
155
Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women
156
Hepatitis C with and without dermatological manifestations: comparison of human leukocyte antigen-DR types, circulating T-cell subsets, and relation to disease severity
157
Hepatitis C, ,
158
Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions
159
Hepatitis C. Biomedical Research Reports: T. Jake Liang and Jay H. Hoofnagle (Eds.), Academic Press, 2000, ISBN 0-12-447870-0, $99.95
160
HEPATITIS C: A COMMON BUT INFREQUENTLY TREATED DISEASE
161
HEPATITIS C: A LEADING CAUSE OF CIRRHOSIS AT DHQ HOSPITAL D.I.KHAN
162
Hepatitis C: molecular virology and antiviral targets
163
Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia
164
Hepatitis C: public health strategies
165
Hepatitis C: the clinical spectrum of the disease
166
Hepatitis C: the dermatologic profile
167
Hepatitis C-Associated Chronic Lymphoproliferative Disorders: A Single Center Experience
168
Hepatitis C-Associated Osteosclerosis After Blood Transfusion
169
Hepatitis C-Associated Osteosclerosis: An Unusual Syndrome of Acquired Osteosclerosis in Adults
170
Hepatitis C—virology and future antiviral targets
171
Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin
172
Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme levels and Histopathology-an Epidemiological Study in Shiraz, Southern Iran, 2003-2004
173
Hepatitis D Is a Forgotten Problem in Hemodialysis Patients in the World
174
Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in “Isolated anti-HBc” Antibodies Profile in Central Tunisia
175
Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
176
Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections
177
Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia)
178
Hepatitis disease diagnosis using a new hybrid system based on feature selection (FS) and artificial immune recognition system with fuzzy resource allocation
179
Hepatitis DVirus Infection among HIV-HBV Co-Infected Patients in Kermanshah, West of Iran
180
Hepatitis E antibodies and HIV status
181
Hepatitis E associated with surgical training on pigs
182
Hepatitis E in Brazil
183
HEPATITIS E SEROCONVERSION IN UNITED STATES TRAVELERS ABROAD
184
Hepatitis E Virus
185
Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death
186
Hepatitis E virus and HIV infection in homosexual men
187
Hepatitis E virus and pigs: A zoonotic risk in Europe?
188
Hepatitis E Virus and Renal Transplantation
189
Hepatitis E virus and serum level aminotransferases in blood donors
190
Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis
191
Hepatitis E virus genotyping based on full-length genome and partial genomic regions
192
Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants
193
Hepatitis E virus infection
194
Hepatitis E Virus Infection Among Chronic Hemodialysis
195
Hepatitis E Virus Infection Among Iranian Patients with Beta-Thalassemia
196
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis
197
Hepatitis E Virus Infection in a Northern Mexican City: A Cross-Sectional Seroprevalence Study
198
Hepatitis E Virus Infection in Hemodialysis Patients: A Seroepidemiological Survey in Jahrom, Southern Iran
199
Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients
200
Hepatitis E Virus Infection in Macaca Mulatta
201
Hepatitis E Virus Infection: A Neglected Problem in Our Region
202
Hepatitis E virus load in swine organs and tissues at slaughterhouse determined by real-time RT-PCR
203
Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran
204
Hepatitis E Virus Seroprevalence Among Liver Transplant Recipients with Persistent Elevation of Liver Enzymes: A Single Center Report
205
Hepatitis E Virus Seroprevalence and Viremia in Hemodialysis and HIV Infected Patients in Iran
206
Hepatitis E virus seroprevalence in haemodialysis patients in Zanjan province, Islamic Republic of Iran
207
Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran
208
Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate
209
Hepatitis E: a virus in waiting
210
Hepatitis E: An emerging awareness of an old disease
211
Hepatitis E: Risk and Prevention
212
Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection
213
Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection
214
Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan‑Iran
215
Hepatitis G virus in immunosuppressed paediatric allograft recipients
216
Hepatitis G virus in India
217
Hepatitis G virus in Karachi, Pakistan
218
Hepatitis G virus in long-term survivors of haematological malignancy
219
Hepatitis G virus infection
220
Hepatitis G virus infection
221
Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy
222
Hepatitis G Virus Infection in Iranian Blood Donors and High-Risk Groups
223
Hepatitis G-associated aplastic anaemia
224
Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany
225
Hepatitis in Ontario linked to EEG electrodes
226
Hepatitis induced by Kava (Piper methysticum rhizoma)
227
Hepatitis meeting suggests end of “carrier” status
228
Hepatitis Monthly, an International Journal in the Field of Hepatology
229
Hepatitis patients lost to follow-up at a liver centre in a tertiary care hospital of Karachi, Pakistan — a cross-sectional descriptive study
230
Hepatitis treatment in developing countries
231
Hepatitis treatment moves on
232
Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma
233
Hepatitis virus infection and atherosclerosis: reply to Vassalle, Zucchelli and Giustini
234
Hepatitis Virus Infection and Hodgkin s Lymphoma: A Review of the Literature
235
Hepatitis virus infections in heart transplant recipients
236
Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment
237
Hepatitis viruses and the MAPK pathway: is this a survival strategy?
238
Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes
239
Hepatitis viruses in the XXI century
240
Hepatitis: A Rapidly Spreading Viral Infection in Pakistan
241
Hepatitis-B vaccine down under
242
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
243
Hepatitis-C and Hepatitis-B Co-Infections in Patients with Human Immunodeficiency Virus in Tehran, Iran
244
Hepatitis-C Infection Incidence Among the non-Hodgkin’s B-cell Lymphoma Patients in the Northeast of Iran
245
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
246
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
247
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
248
Hepatitis-C-virus risk from Italian fertility centre
249
Hepatitis-E-associated fulminant hepatic failure in non-pregnant young women
250
Hepato- and Reno-Protective Impacts of Plantago major: An Experimental Model of Testicular Ischemia/Reperfusion
251
Hepato Protective and Antioxidant Role of Berberis tinctoria Lesch Leaves on Paracetamol Induced Hepatic Damage in Rats
252
Hepatoadrenal syndrome in Egyptian children with liver cirrhosis with and without sepsis
253
Hepatoatrial anastomosis and tricuspid valve replacement in budd-chiari syndrome 8.
254
Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis
255
Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
256
Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen
257
Hepatobiliary Cystadenoma Mimicking Liver Hydatid Cyst
258
Hepatobiliary Cystadenoma with Mesenchymal Stroma Mistaken for Common Bile Duct Stone
259
Hepatobiliary excretion and brain distribution of caffeine in rats using microdialysis Original Research Article
260
Hepatobiliary excretion of 99mTc-EC: A potential source of mistake in the interpretation of renal scintigraphy
261
Hepatobiliary Excretion of Dipyrrinone Sulfonates in Mrp2-Deficient (TR−) Rats
262
Hepatobiliary Fascioliasis: Clinical and Radiological Features
263
Hepatobiliary Involvement in Neonates With COVID-19 Infection: A Narrative Review
264
Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride
265
Hepatobiliary scintigraphy: An effective tool in the management of bile leak following laparoscopic cholecystectomy
266
Hepatobiliary surgeons meet immunologists: the case of colorectal liver metastases patients
267
Hepatobiliary surgery
268
HepatoBiliary Surgery and Nutrition - Message from the Editor-in-Chief
269
Hepatobiliary Surgery and Nutrition is indexed by SCIE: a tremendous step forward
270
Hepatobiliary surgery: the past, present, and future learned from Professor Henri Bismuth
271
Hepatobiliary transport
272
Hepatobiliary, renal and bone complications of intestinal failure
273
Hepatoblastoma in a 2-year-old child of a liver-transplanted mother
274
Hepatoblastoma in a patient with a partial trisomy 9p syndrome: a case report
275
Hepatoblastoma Related Tumor Thrombosis Extended to IVC, Ra and Pulmonary Artery Branches: A Case Report
276
Hepatoblastomas in Oman
277
Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
278
Hepatocarcinogenesis: A polygenic model of inherited predisposition to cancer
279
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
280
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
281
Hepatocellular adenoma displaying a HNF1α inactivation in a patient with familial adenomatous polyposis coli
282
Hepatocellular adenomas in patients taking danazol for here ditary angiooedema
283
Hepatocellular Cancer: A Guide for the Internist
284
Hepatocellular carcinoma
285
Hepatocellular carcinoma
286
Hepatocellular carcinoma
287
Hepatocellular carcinoma
288
Hepatocellular carcinoma
289
Hepatocellular carcinoma
290
Hepatocellular carcinoma
291
Hepatocellular carcinoma
292
Hepatocellular carcinoma (HCC) recurrence and what to do when it happens
293
Hepatocellular carcinoma after radiofrequency ablation therapy: Dynamic CT evaluation of treatment
294
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol
295
Hepatocellular Carcinoma and Academic Skills Workshop cosponsored by Hepatobiliary Surgery and Nutrition and AME Publishing Company
296
Hepatocellular carcinoma and extrahepatic primary malignancy
297
Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran
298
Hepatocellular carcinoma and the art of prognostication
299
Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?
300
Hepatocellular carcinoma development in cirrhosis
301
Hepatocellular Carcinoma Diagnosis Based on Ultrasound Images Using Feature Selection Techniques and K-nearest Neighbor Classifier
302
Hepatocellular carcinoma from diagnosis to treatment: 15 years of challenges and modification of resection strategies
303
Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report
304
Hepatocellular Carcinoma in a non-B non-C Non-alcoholic Steatohepatitis (NBNC-NASH HCC)
305
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal α-fetoprotein
306
Hepatocellular carcinoma in a young survivor of major burns
307
Hepatocellular carcinoma in alcoholics
308
Hepatocellular Carcinoma in Dog – Case Report
309
HEPATOCELLULAR CARCINOMA IN EGYPTIANS WITH AND WITHOUT A HISTORY OF HEPATITIS B VIRUS INFECTION: ASSOCIATION WITH HEPATITIS C VIRUS (HCV) INFECTION BUT NOT WITH HCV RNA LEVEL
310
Hepatocellular Carcinoma in Explanted Livers of Patients with Genotype D HBV Cirrhosis: Report of the First Experience from Iran
311
Hepatocellular Carcinoma in Pakistan: Where do We Stand?
312
Hepatocellular carcinoma in patients suffering from primary sclerosing cholangitis
313
Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors
314
Hepatocellular carcinoma in patients with HCV
315
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
316
Hepatocellular Carcinoma in Port Harcourt, Nigeria: Clinicopathologic Study of 75 Cases
317
Hepatocellular Carcinoma in Pregnancy with Unusual Presentations
318
Hepatocellular Carcinoma in Sheep.
319
Hepatocellular Carcinoma in Sheep.
320
Hepatocellular carcinoma in situs inversus totalis-a case report
321
Hepatocellular Carcinoma in the World and the Middle East
322
Hepatocellular Carcinoma in Two Patients with Autoimmune Hepatitis, A Single Center Experience and Review of the Literature
323
Hepatocellular Carcinoma is an Emerging Issue Now in Iran
324
Hepatocellular carcinoma markers in the omics era: the glycomic analysis
325
Hepatocellular carcinoma on the increase in USA
326
Hepatocellular carcinoma with disseminated skeletal muscle metastasis
327
Hepatocellular carcinoma with extension into the right atrium
328
Hepatocellular Carcinoma With Intracavitary Cardiac Involvement: A Case Report and Review of the Literature
329
Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation
330
Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM
331
Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy
332
Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver
333
Hepatocellular Carcinoma: A Pledge for Evidence-based Medicine
334
Hepatocellular carcinoma: an entity needed to be differentiated
335
Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit
336
Hepatocellular Carcinoma: An Update
337
Hepatocellular carcinoma: beyond screening
338
Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Review
339
Hepatocellular Carcinoma: First Manifestation as SolitaryHumeral Bone Metastasis
340
Hepatocellular Carcinoma: From Molecular Basis to Novel Treatment Approaches
341
Hepatocellular carcinoma: present status and future prospects
342
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
343
Hepatocellular Damage and Severity of COVID-19 Infection in Iraqi Patients: A Biochemical Study
344
Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective
345
Hepatocellular functions of human liver cells in oxygen-permeable membrane device Original Research Article
346
Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity
347
Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide
348
Hepatocellular oxidative stress and initial graft injury in human liver transplantation
349
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
350
Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury
351
Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?
352
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: kinetic evidence for a high affinity/low capacity sinusoidal membrane system
353
HepatoConsult: a knowledge-based second opinion and documentation system
354
Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata
355
Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins
356
Hepatocyte and Islet Cell Cotransplantation on Poly-L-Lactide Matrix for the Treatment of Liver Cirrhosis
357
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
358
Hepatocyte behavior on synthetic glycopolymer matrix: inhibitory effect of receptor–ligand binding on hepatocyte spreading
359
Hepatocyte culture on carbohydrate-modified star polyethylene oxide hydrogels
360
Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces
361
Hepatocyte growth factor (HGF)-induced activation of the AP-1 complex : a comparison between normal and transformed rat hepatocytes
362
Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis
363
Hepatocyte growth factor activates the AP-1 complex: a comparison between normal and transformed rat hepatocytes
364
Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer
365
Hepatocyte growth factor and its actions in growth plate chondrocytes
366
Hepatocyte growth factor and placental development
367
Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease
368
Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
369
Hepatocyte growth factor in gingival crevicular fluid and the distribution of hepatocyte growth factor-activator in gingival tissue from adult periodontitis
370
Hepatocyte growth factor in human amniotic fluid promotes the migration of fetal small intestinal epithelial cells, ,
371
Hepatocyte growth factor induces activation of Nck and phospholipase C-γ in lung carcinoma cells
372
Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line
373
Hepatocyte growth factor inhibits insulin-stimulated glycogen synthesis in primary cultured hepatocytes
374
Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques
375
Hepatocyte growth factor level in the vitreou of patient with proliferative vitreoretinopathy
376
Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1α, and stem cell factor
377
Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis
378
Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis
379
Hepatocyte Growth Factor Regulation of Uterine Epithelial Cell Transepithelial Resistance and Tumor Necrosis Factor (alpha)Release in Culture
380
Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues
381
Hepatocyte growth factor/scatter factor, angiogenesis and tumour cell proliferation in primary breast cancer
382
Hepatocyte growth factor: a multifunctional cytokine
383
Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-κB
384
Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
385
Hepatocyte Isolation From Unused/Rejected Livers for Transplantation: Initial Step Toward Hepatocyte Transplantation, the First Experience From Iran
386
Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
387
Hepatocyte nuclear factor (HNF)-4α/γ, HNF-1α, and vHNF-1 regulate the cell-specific expression of the human dihydrodiol dehydrogenase (DD)4/AKR1C4 gene
388
Hepatocyte Nuclear Factor 1 α Controls Renal Expression of the Npt1-Npt4 Anionic Transporter Locus
389
Hepatocyte Nuclear Factor 4 Alpha Ligand Binding and F Domains Mediate Interaction and Transcriptional Synergy with the Pancreatic Islet LIM HD Transcription Factor Isl1
390
Hepatocyte Nuclear Factor 4 Is a Transcription Factor that Constitutively Binds Fatty Acids
391
Hepatocyte Nuclear Factor 4-Mediated Activation of Rat CYP3A1 Gene and Its Modes of Modulation by Apolipoprotein AI Regulatory Protein I and v-ErbA-Related Protein 3
392
Hepatocyte nuclear factor-4α plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver
393
Hepatocyte performance on different crystallographic faces of rutile
394
Hepatocyte Polyploidy and Metabolism/Life-history Traits: Hypotheses Testing
395
Hepatocyte proliferation – can we target the mechanism?
396
Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis
397
Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling
398
Hepatocyte proliferative activity in human liver cirrhosis
399
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
400
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a
401
Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies
402
Hepatocyte vacuolation and autolytic changes in the liver of pilot whales, Globicephala melas, stranded on Cape Cod, MA, USA
403
Hepatocyte-Derived MicroRNAS as Serum Predictors of Rejection of Liver Transplantation
404
Hepatocytes as a source of collagen type XVIII endostatin
405
Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells
406
Hepatocyte-supported serum-free culture of rat liver sinusoidal endothelial cells
407
Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature
408
Hepatoid carcinoma of the pancreas mimicking neuroendocrine tumor
409
Hepatoid Variant of Yolk Sac Tumor of Both Ovaries With Widespread Intraabdominal and Lung Metastasis: A Case Report
410
Hepatologie : Edited by Gerok/Blum, 942, Urban & Schwarzenberg, US $ 398, ISBN 3-541-12272-2
411
Hepatology may have problems with putative surrogate outcome measures
412
Hepatoma-derived Growth Factor Represses SET and MYND Domain Containing 1 Gene Expression through Interaction with C-terminal Binding Protein
413
Hepatomegaly: A Major Clinical Sign in Some Metabolic Disorders
414
Hepatopancreas mitochondria of Mytilus galloprovincialis: effect of zinc ions on mitochondrial bioenergetics and metabolism
415
Hepatopancreatic nuclease of black tiger shrimp Penaeus monodon unlikely to be involved in viral triggered apoptosis
416
Hepatopathy and Reno-cardiopathy Induced by Ritalin in Rats
417
Hepatoprotection of sesquiterpenoids: A quantitative structure–activity relationship (QSAR) approach
418
Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats
419
Hepatoprotective Activity of “Orthosiphon stamineus” on Liver Damage Caused by Paracetamol in Rats
420
Hepatoprotective activity of aerial parts of Otostegia persica against carbon tetrachloride-induced liver damage in rats
421
Hepatoprotective activity of Amaranthus spinosus in experimental animals
422
Hepatoprotective activity of Andrographis Paniculata and Swertia Chirayita
423
Hepatoprotective Activity of Camellia Sinensis and Its Possible Mechanism of Action
424
Hepatoprotective Activity of Capparis spinosa Root Bark Against CCl4 Induced Hepatic Damage in Mice
425
Hepatoprotective Activity of Caspian Saffron (Crocus caspius Fisch and Mey) Flowers against CCl4 Induced Acute Liver Injury in Mice
426
Hepatoprotective Activity of Cichorium intybus L. Leaves Extract Against Carbon Tetrachloride Induced Toxicity
427
Hepatoprotective activity of colocasia antiquorum against experimentally induced liver injury in rats
428
Hepatoprotective Activity of Cucumis trigonus Roxb. Fruit against CCl4 Inducesd Hepatic Damage in Rats
429
HEPATOPROTECTIVE ACTIVITY OF Iphiona grantioides AND Pluchea arguta FOR ACETAMINOPHEN INDUCED TOXICITY IN RABBITS
430
Hepatoprotective activity of Mammea africana ethanol stem bark extract
431
Hepatoprotective Activity of Momordica diocia Roxb Fruits in CCl4-Induced Hepatotoxicity in Rats
432
Hepatoprotective activity of phloretin and hydroxychalcones against Acetaminophen Induced hepatotoxicity in mice
433
HEPATOPROTECTIVE ACTIVITY OF PHYLLANTHUS RETICULATUS
434
Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: A randomized controlled trial
435
Hepatoprotective activity of royal jelly on mercuric chloride–induced damage model in rats
436
Hepatoprotective activity of Schouwia thebica webb
437
Hepatoprotective activity of the ethanol extract of Curcuma heyneana rhizome on isoniazid and rifampin-induced liver injury rats
438
Hepatoprotective Activity of the Ethanolic Extract of Ficus carica Linn. Leaves in Carbon Tetrachloride-Induced Hepatotoxicity in Rats
439
Hepatoprotective activity of the extract of Homalium letestui stem against paracetamol-induced liver injury
440
Hepatoprotective activity of the total flavonoids from Rosa laevigata Michx fruit in mice treated by paracetamol
441
Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides Original Research Article
442
Hepatoprotective and antifibrotic effects of trans-chalcone against bile duct ligation-induced liver fibrosis in rats
443
Hepatoprotective and antiobesity effects of mirabegron, a novel β3-adrenoceptor agonist, on carbon tetrachloride-induced hepatotoxicity in obese rats
444
Hepatoprotective and Antioxidant Activities of Combination of Cinnamomum zeylanicum and Zingiber officinale in CCl4intoxicated Rats
445
Hepatoprotective and antioxidant activity of ethanolic extracts of edible lotus (Nelumbo nucifera Gaertn.) leaves
446
Hepatoprotective and Antioxidant Activity of Euphorbia tirucalli
447
Hepatoprotective and antioxidant effects of Azolla microphylla based gold nanoparticles against acetaminophen induced toxicity in a fresh water common carp fish (Cyprinus carpio L.)
448
Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO2 on CCl4-induced liver damage
449
Hepatoprotective and antioxidant effects of Commiphora berryi (Arn) Engl bark extract against CCl4-induced oxidative damage in rats
450
Hepatoprotective and Antioxidant Effects of Eupatorium ayapana against Carbon Tetrachloride Induced Hepatotoxicity in Rats
451
Hepatoprotective and antioxidant effects of lycopene in acute cholestasis
452
Hepatoprotective and Anti-oxidant effects of Nepeta Ispahanica Boiss extract on CCL4 induced liver Injury
453
Hepatoprotective and antioxidant effects of porcine plasma protein hydrolysates on carbon tetrachloride-induced liver damage in rats
454
Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice
455
Hepatoprotective and antioxidant polyphenols from a standardized methanolic extract of the leaves of Liquidambar styraciflua L.
456
Hepatoprotective and antioxidative effects of total phenolics from Laggera pterodonta on chemical-induced injury in primary cultured neonatal rat hepatocytes
457
Hepatoprotective and Hypolipidemic Effects of Carthamus tinctorius oil in Alloxan-induced Type 1 Diabetic Rats
458
Hepatoprotective and Hypolipidemic Effects of Satureja Khuzestanica Essential Oil in Alloxan-induced Type 1 Diabetic Rats
459
Hepatoprotective and hypolipidemic effects of water-soluble polysaccharidic extract of Pleurotus eryngii
460
Hepatoprotective and nitric oxide production inhibitory activities of coumarin and polyacetylene constituents from the roots of Angelica furcijuga
461
Hepatoprotective constituents from Zedoariae Rhizoma: absolute stereostructures of three new carabrane-type sesquiterpenes, curcumenolactones A, B, and C Original Research Article
462
Hepatoprotective effect and antioxidant role of sun, sulphited-dried apricot (Prunus armeniaca L.) and its kernel against ethanol-induced oxidative stress in rats
463
Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis
464
Hepatoprotective Effect of 17β-Estradiol as Antioxidant Modulators Against Stress Damage
465
Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats
466
Hepatoprotective effect of Acantholimon bracteatum (Girard) Boiss. on formaldehyde-induced liver injury in adult male mice
467
Hepatoprotective Effect of Adenema hyssopifolium G. Don (Gentianaceae) in Carbon Tetrachloride-Induced Hepatotoxicity in Rats
468
Hepatoprotective Effect of Allium hooshidaryae Hydroalcoholic Extract on Acetaminophen-Induced Hepatotoxicity in Male Rats
469
Hepatoprotective Effect of Alpha Lipoic Acid Against Bromobenzene-Induced Liver Damage in Rats
470
Hepatoprotective Effect of an Indian Salt Marsh Herb Suaeda Monoica Forsk. Ex. Gmel Against Concanavalin-A Induced Toxicity in Rats
471
Hepatoprotective Effect of Aqueous Extract of Persian Gulf Brown Algae Sargassum swartzii Against Acetaminophen-Induced Hepatotoxicity in Mice
472
HEPATOPROTECTIVE EFFECT OF CARNOSINE ON LIVER BIOCHEMICAL PARAMETERS IN CHRONIC ETHANOL INTOXICATED RAT
473
Hepatoprotective effect of chitooligosaccharides against tert-butylhydroperoxide-induced damage in Chang liver cells
474
Hepatoprotective Effect of Coenzyme Q10 in Rats with Diclofenac Toxicity
475
Hepatoprotective Effect of Cornus mas Fruits Extract Against Carbon Tetrachloride-Induced Hepatic Damage in Male Albino Rats
476
Hepatoprotective effect of Crocus sativus (saffron) petals extract against acetaminophen toxicity in male Wistar rats
477
Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice
478
Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice
479
Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice
480
Hepatoprotective Effect of Ethanolic Extract of Lavandula officinalis L. in Alloxan-Induced Diabetic Rats
481
hepatoprotective effect of ethanolic extract of lavandula officinalis l.in alloxan-induced diabetic rats
482
Hepatoprotective Effect of Ficus carica Leaf Extract on Mice Intoxicated with Carbon Tetrachloride
483
HEPATOPROTECTIVE EFFECT OF GARLIC (ALLIUM SATIVUM) AND MILK THISTLE (SILYMARIN) IN ISONIAZID INDUCED HEPATOTOXICITY IN RATS
484
Hepatoprotective Effect of Glycyrrhiza Glabra in Carbon Tetrachloride-Induced Model of Acute Liver Injury
485
Hepatoprotective effect of herbal drug on CCl4 induced liver damage
486
Hepatoprotective effect of kaempferol glycosides isolated from Cedrela odorata L. leaves in albino mice: involvement of Raf/MAPK pathway
487
Hepatoprotective Effect of Lactobacillus Plantarum Against Salmonella Typhimurium in Mice
488
Hepatoprotective Effect of Matricaria chamomilla Hot Aqueous Extract Against Methomyl 90%- Induced Hepatotoxicity In Mice
489
Hepatoprotective Effect of Microemulsion-Based System of
Prunus Cerasus
Kernel Extract on CCL
4
-induced Liver Damage in Mice
490
HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE
491
HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE
492
Hepatoprotective effect of mulberry water extracts on ethanol-induced liver injury via anti-inflammation and inhibition of lipogenesis in C57BL/6J mice
493
Hepatoprotective Effect of Otostegia persica Boiss. Shoot Extract on Carbon Tetrachloride-Induced Acute Liver Damage in Rats
494
Hepatoprotective effect of polyphenols rich methanolic extract of Amorphophallus commutatus var. wayanadensis against CCl4 induced hepatic injury in swiss albino mice
495
Hepatoprotective Effect of Pomegranate (Punica Granatum) Fruit Juice and Seed Extracts against CCL4-Induced Toxicity
496
Hepatoprotective effect of Rosa canina fruit extract against carbon tetrachloride induced hepatotoxicity in rat
497
Hepatoprotective effect of Rosmarinus officinalis and rosmarinic acid on acetaminophen-induced liver damage
498
Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect
499
Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect
500
Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism
501
Hepatoprotective Effect of Silymarin and Propolis in Chemically Induced Chronic Liver Injury in Rats
502
Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats
503
Hepatoprotective effect of the root extract of green tea against malathion-induced oxidative stress in rats
504
hepatoprotective effect of vitamin b12 in acetaminophen induce hepatotoxicity in male rats
505
Hepatoprotective effect of vitamins C and E against gasoline vapor-induced liver injury in male rats
506
Hepatoprotective Effect of Zizyphus vulgaris on Carbon Tetrachloride (CCl4) Induced Liver Damage in Rats as Animal Model
507
Hepatoprotective effect of β-myrcene pretreatment against acetaminophen-induced liver injury
508
Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin
509
Hepatoprotective effects of almond oil against carbon tetrachloride induced liver injury in rats
510
Hepatoprotective Effects of Arbutin against Liver Damage Induced by Carbon Tetrachloride in Rats
511
Hepatoprotective effects of Artemia salina L. extract against carbon tetrachloride-induced toxicity
512
Hepatoprotective Effects of Avicennia marina (Forssk.) Vierh.
513
HEPATOPROTECTIVE EFFECTS OF BERBERIS LYCIUM, GALIUM APARINE AND PISTACIA INTEGERRIMA IN CARBON TETRACHLORIDE (CCL4)-TREATED RATS
514
Hepatoprotective effects of betaine on liver damages followed by myocardial infarction
515
Hepatoprotective Effects of Biochanin A Against Acetaminophen-Induced Liver Toxicity in Mice
516
Hepatoprotective Effects of Black Pomegranate (Punica granatum L.) Peel Extract on Tert-Butyl Hydroperoxide Induced Oxidative Stress in Rats
517
Hepatoprotective effects of chestnut (Castanea crenata) inner shell extract against chronic ethanol-induced oxidative stress in C57BL/6 mice
518
Hepatoprotective Effects of Chitosan and Chitosan Nanoparticles against Biochemical, Genetic, and Histological Disorders Induced by the Toxicity of Emamectin Benzoate
519
Hepatoprotective Effects of Coenzyme Q10 against Amoxiclav-induced Hepatotoxicity in the Rat Model
520
Hepatoprotective Effects of Combination Hydroalcoholic Extracts of Nigella Sativa and Curcuma Longa on Adriamycin- Induced Oxidative Stress in Rat
521
Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice
522
Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury
523
Hepatoprotective Effects of Ethanol Extract of Caesalpiniabonduc against Carbon Tetrachloride Induced Hepatotoxicity in Albino Rats
524
Hepatoprotective effects of fermented Curcuma longa L. on carbon tetrachloride-induced oxidative stress in rats
525
Hepatoprotective effects of fermented field water-dropwort (Oenanthe javanica) extract and its major constituents
526
Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats
527
Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice
528
Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on Nuclear Factor-kappa B pathway in thioacetamide-induced fibrosis in rats
529
Hepatoprotective Effects of Hertia cheirifolia Butanolic Extract and Selenium against CCl4 -induced Toxicity in Rats
530
Hepatoprotective effects of hydroethanolic extracts of Crocus sativus tepals, stigmas and leaves on carbon tetrachloride induced acute liver injury in rats
531
Hepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in mice
532
Hepatoprotective effects of Lycium chinense Miller fruit and its constituent betaine in CCl4-induced hepatic damage in rats
533
Hepatoprotective effects of Malva sylvestris L. against paracetamol-induced hepatotoxicity
534
Hepatoprotective Effects of Opuntia dillenii Haw Fruit in a Mice Model of Lung Cancer
535
Hepatoprotective Effects of Pentoxifylline against Acrolein-Induced Mitochondrial Dysfunction in Rat Liver
536
Hepatoprotective effects of Platycodon grandiflorum on acetaminophen-induced liver damage in mice
537
Hepatoprotective Effects of Propolis Extract: A Biochemical and Histopathological Approach
538
Hepatoprotective effects of purified oleuropein from olive leaf extract against ethanol-induced damages in the rat
539
Hepatoprotective Effects of Silymarin on Liver Injury via Irisin Upregulation and Oxidative Stress Reduction in Rats with Type 2 Diabetes
540
Hepatoprotective Effects of Taraxacum officinale Root Extract on Permethrin-induced Liver Toxicity in Adult Mice
541
Hepatoprotective effects of total saponins isolated from Taraphochlamys affinis against carbon tetrachloride induced liver injury in rats
542
Hepatoprotective efficacy of Grewia asiatica fruit against oxidative stress in swiss albino mice
543
Hepatoprotective Evaluation of Butea monosperma against Liver damage by Paracetamol in Rabbits
544
Hepatoprotective glycosides from Leonurus japonicus Houtt. Original Research Article
545
Hepatoprotective Herbs, Avicenna Viewpoint
546
Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins
547
Hepatoprotective potential and antioxidant activity of Allium tripedale in acetaminophen-induced oxidative damage
548
Hepatoprotective potential of polyphenol rich extract of Murraya koenigii L.: An in vivo study
549
Hepatoprotective Potential of Prosopis farcta Beans Extracts against Acetaminophen-induced Hepatotoxicity in Wister Rats
550
Hepatoprotective potential of Saraca ashoka (Roxb.) De Wilde bark by carbon tetrachloride induced liver damage in rats
551
Hepatoprotective potentials of Phyllanthus amarus against ethanol-induced oxidative stress in rats
552
Hepatoprotective principles from the flowers of Tilia argentea (Linden): structure requirements of tiliroside and mechanisms of action Original Research Article
553
Hepatoprotective Properties of Cuminum cyminum Seeds Powder as Post-Treatment for Acetaminophen-Induced Injury
554
Hepatoprotective properties of p-coumaric acid in a rat model of ischemiareperfusion
555
Hepatoprotective properties of sesamin against CCl4 induced oxidative stress-mediated apoptosis in mice via JNK pathway
556
Hepatoprotective properties of the glycolipoprotein extract from Eisenia foetida
557
Hepatoprotective pyrrole derivatives of Lycium chinense fruits
558
Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats
559
Hepatoprotective Role of Milk Thistle (Silybum marianum) in Meat Type Chicken Fed Aflatoxin B1 Contaminated Feed
560
HEPATOPROTECTIVE STUDIES ON HALOXYLON SALICORNICUM: A PLANT FROM CHOLISTAN DESERT
561
Hepatoprotective, anti-inflammatory and antioxidant activities of Flacourtia montana J. Grah leaf extract in male Wistar rats
562
Hepatoprotective, superoxide scavenging, and antioxidative activities of aromatic constituents from the bark of Betula platyphylla var. japonica
563
Hepatoprotetive, Cardioprotective and Nephroprotective Actions of Essential Oil Extract of Artemisia sieberi in Alloxan Induced Diabetic Rats
564
Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study
565
Hepatopulmonary syndrome associated with Budd-Chiari syndrome
566
Hepatopulmonary syndrome associated with cardiorespiratory disease
567
Hepatopulmonary syndrome in candidates for liver transplantation
568
Hepatopulmonary syndrome in patients with Schistosoma mansoni periportal fibrosis
569
Hepatopulmonary syndrome in transplant centres at different altitudes
570
Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data
571
Hepatopulmonary syndrome: Angiography and therapeutic embolization
572
Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS)
573
Hepatorenal and genotoxic effects of genetically modified quail meat in a 90-day dietary toxicity study in mice
574
Hepatorenal and Testicular Functions Concomitant with Induced Hypo and Hyperprolactinemia in Male Rats
575
Hepato-Renal Dysfunctions Induced by Gold Nanoparticles and Preservative Efficacy of Black Seed Oil
576
Hepatorenal effect of prolonged low-flow sevoflurane anesthesia on patients with renal impairment
577
Hepatorenal Protective Effects of Sesame Seeds Oil, Flaxseed Oil and their Mixture against Methotrexate Toxicity in Rats
578
Hepatorenal syndrome
579
Hepatorenal syndrome: Response to terlipressin and albumin and its determinants
580
Hepatorenal-toxicities Accompanying Exposure to Indoor Air Pollutants in Chemical Storekeepers at an International Market
581
Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors
582
Hepatosplenic Candidiasis Detected by ^18F-FDG-PET/CT
583
Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India
584
Hepato-Splenic gamma sigma T-Cell Lymphoma: A Rare Entity Mimicking the Hemophagocytic Syndrome
585
HEPATOSPLENIC MORBIDITY IN SCHISTOSOMIASIS JAPONICA: EVALUATION WITH DOPPLER SONOGRAPHY
586
Hepatosplenic Mucor Balls
587
Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum
588
Hepatosplenic γδ T cell lymphoma: a diagnostic pitfall
589
Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase −1 exon 8 splice junction mutation
590
Hepatotoxic and Nephrotoxic Effects of Kerosene on Female Wistar Rats: a Comparison of Two Routes of Exposure
591
Hepatotoxic Effect of Hydrogen Cyanamide (Dormex®) in Albino Rats and the Ameliorative Effect of Melatonin
592
HEPATOTOXIC EFFECT OF NICKEL SULPHATE ON MICE
593
Hepatotoxic effects of mycotoxin combinations in mice
594
Hepatotoxic microcystin diversity in cyanobacterial blooms collected in portuguese freshwaters
595
Hepatotoxicity After Exposure to Tebuconazole: A Case Report and Brief Review
596
Hepatotoxicity Among Poisoned Patients: A Cross-sectional Study
597
Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice
598
Hepatotoxicity and genotoxicity of patulin in mice, and its modulation by green tea polyphenols administration
599
Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice
600
HEPATOTOXICITY ASSOCIATED WITH HYPOGLYCEMIC EFFECTS OF TEUCRIUM POLIUM IN DIABETIC RATS
601
Hepatotoxicity associated with the ingestion of Papaver Rhoease
602
Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)
603
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): A growing concern
604
Hepatotoxicity Due To Mushroom Poisoning: A Case Report
605
Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting
606
Hepatotoxicity in Both Occupationally and Environmentally-Exposed Inhabitants of a Lead-Zinc Mining Community
607
Hepatotoxicity in drug development: detection, significance and solutions
608
Hepatotoxicity in sheep and goats caused by experimental feeding with foxtail millet (Setariaitalica)
609
Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study
610
Hepatotoxicity induced by iron overload and alcohol : Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation
611
Hepatotoxicity of androstenedione in pregnant rats
612
Hepatotoxicity of Antiretroviral Drugs in HIV Seropositive Nigerian Patients
613
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
614
HEPATOTOXICITY OF CARBON TETRACHLORIDE: PROTECTIVE EFFECT OF GONGRONEMA LATIFOLIUM
615
Hepatotoxicity of Dorema Aucheri (Bilhar) in Albino Mice
616
Hepatotoxicity of Halogenated Inhalational Anesthetics
617
Hepatotoxicity of herbal remedies
618
Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice
619
Hepatotoxicity of monobromobenzene and hexabromobenzene: effects of repeated dosage in rats
620
Hepatotoxicity of non-narcotic analgesics
621
Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials
622
Hepatotoxicity of Polyethylene Glycol and Possible Protection Using Moringa Oleifera Leaves Extract (MOLE)
623
Hepatotoxicity of polyunsaturated fatty acids in alcohol abuser
624
Hepatotoxicity of tubers of Indian Kudzu (Pueraria tuberosa) in rats
625
Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly- -lysine : Synthesis of the carrier and pharmacological properties of the conjugate
626
Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines
627
Hepato-vagal pathway associated with nicotineʹs anorectic effect in the rat
628
Hepatozoon species infections in Nigeria
629
He–Pb double dating of detrital zircons from the Ganges and Indus Rivers: Implication for quantifying sediment recycling and provenance studies
630
Hepcidin and anaemia
631
Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major
632
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload
633
Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients
634
Hepcidin Gene Cloning and Expression Pattern in Turbot (Scophthalmus maximus) after Vibrio. anguillarum Infection
635
Hepcidin gene expression induced in the developmental stages of fish upon exposure to Benzo[a]pyrene (BaP)
636
Hepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytes
637
Hepcidin in hemodialysis patients and its association with anemia and serum iron indices
638
Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction?
639
Hepcidin Induces M1 Macrophage Polarization in Monocytes or THP-1 Derived Macrophages
640
Hepcidin is a friend rather than a foe in COVID19-induced complications
641
Hepcidin mimetics from microorganisms? A possible explanation for the effect of Helicobacter pylori on iron homeostasis
642
Hepcidin, A New Iron Regulatory Peptide
643
Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery
644
Hepcidin: A multitask molecule in fish
645
Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages
646
HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium
647
HEPHESTUS: An expert system in PROLOG for the interpretation of the pyrolysis-mass spectra of polyesters, polyethers and polyureas using the certainty factor model
648
HEPI: A new tool for human error probability calculation for offshore operation
649
HepML, an XML-based format for describing simulated data in high energy physics Original Research Article
650
HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells
651
HEP-NET OPINION ABOUT THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS C IN PAKISTAN IN THE ERA OF AVAILABLE DIRECT ACTING ANTIVIRALS
652
Hepsin promotes prostate cancer progression and metastasis
653
Hept-1-yne partial hydrogenation reaction over supported Pd and W catalysts Original Research Article
654
Heptacoordinate dithiophosphate Mo(II) and W(II) complexes: molecular structures of mono and binuclear phosphine complexes
655
Heptacoordinate dithiophosphate W(II) and Mo(II) complexes of diphosphines and iodide
656
Heptacoordinate tricarbonyl Mo(II) complexes as highly selective oxidation homogeneous and heterogeneous catalysts
657
Heptacoordinated diphenyllead; hexa- and pentacoordinated triphenyllead and tin compounds derived from 5H-benzimidazo[1,2-c]quinazoline-6-thione
658
Heptacyclo[6.6.0.02,6.03,13.04,11.05,9.010,14]tetradecane: a new type of spacer for mediating electron transfer processes
659
Heptadecafluorooctanesulfonic acid (C8F17SO3H) catalyzed intramolecular hydroamination of olefinic sulfonamides in fluorous biphase system (FBS)
660
Heptadecanols from the leaves of Persea americana var. americana
661
Heptadentate Schiff-base based PVC membrane sensor for Fe(III) ion determination in water samples
662
Heptahelical receptor signaling in heart failure
663
Heptakis(2,3-di-O-carboxymethyl)-(beta)-cyclodextrin as a pH-sensitive Host
664
Heptakis(6-deoxy-6-guanidino)-β-cyclodextrin: an artificial model for mitochondrial ADP/ATP carrier
665
Heptakis[6-S-(2,3-dihydroxypropyl)-6-thio] cyclomaltoheptaose and its sulfone: water-soluble β-cyclodextrin derivatives having modified polarity
666
Heptakis-6-(5-methylene-thioureido-5′-methyl-2,2′-bipyridyl)-β-cyclodextrin: synthesis and metal complexation study
667
Heptakis-6-(5-methylene-ureido-5′-methyl-2,2′-bithiazolyl)-cyclomaltoheptaose as a new fluorescent polydentate ligand
668
Heptane isomerization over molybdenum oxides obtained by H2 reduction of HxMoO3 with different hydrogen contents Original Research Article
669
Heptane Reforming over Pt–Re/Al2O3: Reaction Network, Kinetics, and Apparent Selective Catalyst Deactivation
670
Heptanuclear and Decanuclear Manganese Complexes with the Anion of 2-Hydroxymethylpyridine
671
Heptanuclear cobalt(II) dicubane compounds with single-molecule magnet behavior
672
Heptaphyrins: Expanded porphyrins with seven heterocyclic rings
673
Heptyl oleate synthesis as useful tool to discriminate between lipases, proteases and other hydrolases in crude preparations
674
Her 2 in 1
675
Her 2 Overexpression in Breast Carcinoma; Its Significance and Association with Age and Tumor Grade
676
Her Majesty’s coroners and Home Office forensic pathologists perception of the nurses’ role in the coroner’s enquiry
677
Her records
678
Her story of cognitive science
679
HER2 aberrations in cancer: Implications for therapy
680
HER2 and proliferation of wound-induced breast carcinoma
681
HER2 and proliferation of wound-induced breast carcinoma
682
HER2 and proliferation of wound-induced breast carcinoma
683
HER2 and surgery: more questions to answer
684
HER2 discordance between primary and metastatic breast cancer: Assessing the clinical impact
685
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization
686
HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma
687
HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer—A study of two hundred cases
688
HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer
689
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors
690
HER2 Overexpression in Borderline and Malignant Ovarian Tumors: A Cross-sectional Study in an Iranian Population and Literature Review
691
HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription
692
HER2 Protein Overexpression in Infiltrating Ductal Carcinoma of the Breast Associated with Lymph Node Involvement
693
HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana
694
HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
695
HER2 status and UPA/PAI-1 provide complementary information on patient outcome in node-negative breast cancer
696
HER2 status in advanced breast cancer: which option for aromatase inhibitors?
697
HER2 Testing in Invasive Breast Cancer: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization Assays
698
HER2 testing: Current status and future directions
699
HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?
700
HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia
701
HER2/neu expression in bladder cancer: relationship to cell cycle kinetics
702
Her-2/Neu Expression in Bladder Urothelial Carcinoma
703
HER-2/neu Expression in Resectable Gastric Cancer and its Relationship with Histopathologic Subtype, Grade, and Stage
704
Her2/neu Expression in Wilmsʹʹ Tumor and Correlation With Histopathologic Findings
705
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
706
HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
707
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
708
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
709
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
710
Her-2/Neu, Estrogen and Progesterone Receptor Expression In WHO Grade I Meningiomas
711
HER2/neu: A Prognostic Marker for Ovarian Carcinoma
712
HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization
713
HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
714
HER2-Positive Breast Cancer: Tumor-to-Liver SUV Ratio is the Best Parameter for Detection in F-18 FDG-PET/CT
715
Her2-specific Multivalent Adapters Confer Designed Tropism to Adenovirus for Gene Targeting
716
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
717
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
718
HER-3 Knocking Down Induces G2/M Arrest in Gastric Cancer Cells
719
HER4 rs1595065 3ʹUTR Variant is a Possible Risk Factor for HER2 Positivity Among Breast Cancer Patients
720
HERA and the asymptotic behaviour of F2p
721
HERA anomaly and hard charm in the nucleon
722
HERA collider physics
723
HERA data and DGLAP evolution: Theory and phenomenology
724
HERA events, tevatron jets, and uncertainties on quarks at large x
725
HERA prospects on compositeness and new vector bosons
726
HERA results on electroweak interactions at high momentum transfers
727
HERA results on the structure of the proton
728
HERA today, gone tomorrow?
729
HERA-3 Original Research Article
730
HERA-B data acquisition system
731
HERA-B data acquisition system
732
HERA-B framework for online calibration and alignment
733
HERA-B framework for online calibration and alignment
734
HERA-B higher-level triggers: architecture and software
735
HERA-B higher-level triggers: architecture and software
736
HERA-B RICH
737
HERA-B RICH
738
HERA-B RICH light collection system
739
HERA-B RICH light collection system
740
HERA-B RICH: Performance and physics impact
741
HERA-B RICH: Performance and physics impact
742
HERA-B status
743
HERA-B status
744
HERA-B triggering
745
HERA-B, an experiment to study CP violation at the HERA proton ring using an internal target
746
HERA-B: overview and 1996 engineering run
747
HERA-B: overview and 1996 engineering run
748
HERA-B: overview and engineering runs
749
HERA-B: overview and engineering runs
750
HERA-B: physics potential and prospects
751
HERA-B: physics potential and prospects
752
HERA-B: status and commissioning results
753
HERA-B: status and commissioning results
754
HERA-B: trigger system
755
HERA-B: trigger system
756
HERACLES-II setup at TRIUMF
757
HERACLES-II setup at TRIUMF
758
HERA-data in the light of small x evolution with state of the art NLO input
759
Heraeus acquires BASFʹs business in ceramic & glassware colorants
760
Herakles’in On İki İşi Betimli Mozaik Hakkında Tespitler
761
Heralded two-photon entanglement from probabilistic quantum logic operations on multiple parametric down-conversion sources
762
Herb and vitamin upplementation ue among a general ophthalmology practice population
763
Herb digoxin interactions
764
Herb gallwasp Neaylax salviae (Giraud, 1859) (Hymenoptera, Aylacini) – new record from Turkey
765
Herb layer extinction debt in highly fragmented temperate forests – Completely paid after 160 years?
766
Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats
767
Herb Target Prediction Using Machine Learning Methods in a Heterogeneous Network
768
Herbaceous biomass retrieval in habitats of complex composition: a model merging SAR images with unmixed Tlandsat TM data
769
Herbaceous energy crops: A general survey and a microeconomic analysis
770
Herbaceous layer response to 17 years of controlled deer hunting in forested natural areas
771
Herbaceous plant biomass harvest and delivery cost with harvest segmented by month and number of harvest machines endogenously determined
772
Herbaceous vegetation response to grazing exclusion in patches and inter-patches in semi-arid pasture and woody encroachment
773
Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway
774
Herbage and Animal Responses to Management Intensity of Continuously Stocked Bahiagrass Pastures
775
Herbage and Seed Production of Two Species of Lathyrus L. under Rainfed Condition of Borujerd, Iran
776
Herbage biomass production and nutritive value of mulberry (Morus alba) and Calliandra calothyrsus harvested at different cutting frequencies
777
Herbage intake and milk yield of dairy cows grazing perennial ryegrass swards or white clover/perennial ryegrass swards at low- and medium-herbage allowances
778
HERBAGE MINERAL NUTRITION INDEXED AS TOOLS FOR RAPID MINERAL STATUS DIAGNOSIS IN TROPICAL PASTURES
779
Herbage production and chemical characteristics for bioenergy production by plant functional groups from semi-natural grasslands
780
Herbage yield in Signalgrass pastures as affected by grazing management
781
Herbage yield of Persian clover (Trifolium resupinatum L.) as affected by row distance and herbicide application
782
Herbal agents and over-the-counter medications in pregnancy
783
Herbal and Conventional Toothpastes Roles in Gingivitis Control in Orthodontic Patients
784
Herbal and Dietary Supplement–Drug Interactions in Patients Taking Digoxin
785
Herbal and nutritional supplement use among college students in Qatar
786
Herbal Appetizer for Children with Failure to Thrive (FTT) in View of Traditional Persian Medicine: A Review
787
HERBAL APPROACHES FOR EPILEPSY: A REVIEW
788
Herbal Cosmeceuticals for Photoprotection from Ultraviolet B Radiation: A Review
789
Herbal cosmeceuticals: New opportunities in cosmetology
790
Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products
791
Herbal Drugs with Promising Anti-Leishmanial Activity: New Hope for Leishmaniasis Treatment
792
Herbal Extract Decolourization Device Using Activated Carbon
793
Herbal extracts and essential oils microencapsulation studies for different applications
794
Herbal formula CGX ameliorates LPS/d-galactosamine-induced hepatitis
795
Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports
796
Herbal infusions bioelectrochemical polyphenolic index: Green tea – The gallic acid interference
797
Herbal infusions; their phenolic profile, antioxidant and anti-inflammatory effects in HT29 and PC3 cells
798
HERBAL INTAKE: UNDIAGNOSED HYPOTHYROIDISM LEADING TO POSTOPERATIVE REFRACTORY CIRCULATORY COLLAPSE - A Case Report -
799
Herbal Medications to Manage Insomnia: An Overview of Clinical Trials using Herbal Treatment for Insomnia
800
Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential
801
Herbal Medicinal Products, Medpharm, Stuttgart, Germany, F. Gaedcke, B. Steinhoff, H. Blasius (Eds.). CRC Press, Boca Raton, USA (2003)
802
Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry
803
Herbal medicine and liver disease, for any conclusion we need to do more studies
804
Herbal Medicine and Sexual Behavior in Diabetic Patients
805
Herbal Medicine and Vaginal Candidiasis in Iran: A Review
806
Herbal Medicine and Vaginal Candidiasis in Iran: A Review
807
Herbal Medicine as Inducers of Apoptosis in Cancer Treatment
808
Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview
809
Herbal medicine heads for the mainstream
810
Herbal Medicine in the Treatment of Premenstrual Syndromes
811
Herbal Medicine in Treatment of Recurrent Aphthous Stomatitis: A Literature Review
812
Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet
813
Herbal Medicine Isolation, Phaleria macrocarpa for primary glioblastoma multiforme cells
814
Herbal medicine Sho-saiko-to (TJ-9) prevent liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient -amino acid-defined diet
815
Herbal medicine under scrutiny
816
Herbal Medicine, Second Edition.: Rudolf Fritz Wiess, MD and Volker Fintelmann, MD. ISBN 0-86577-970-8, Thieme, NY, 438 pp.
817
Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects
818
Herbal Medicines and Epilepsy: To the Editor
819
Herbal Medicines and Other Traditional Remedies in Iran – A Tragedy Unfolds
820
Herbal Medicines and Reactivation of Chronic Hepatitis B Virus Infection
821
Herbal Medicines for Immunosuppression
822
Herbal Medicines in Diabetes
823
Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders
824
Herbal Medicines Used in Kidney Diseases in Europe
825
Herbal Medicines Used in Treatment of Nonalcoholic Fatty Liver Disease: A Mini-Review
826
Herbal medicines: a new hope for autism therapy
827
Herbal Medicines: from Traditional Medicine to Modern Experimental Approaches
828
Herbal medicines—primum non nocere
829
Herbal Nanoemulsion in Topical Drug Delivery and Skin Disorders: Green Approach
830
Herbal nano-ointment containing encapsulated polysaccharide in repairing of superficial ulcers
831
Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review
832
Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review
833
Herbal Products in the Care and Prevention of Breast Fissure in Lactating Women: A Systematic Review
834
Herbal Products Review Provides Inaccurate Information on Dietary Supplement Regulations
835
Herbal Products Review: What Do We Really Know?
836
Herbal Products Use During Pregnancy in North of Iran
837
Herbal remedies and medicine; introducing some Iranian plants
838
Herbal Remedies CD-ROM, T. Brendler, J. Gruenwald, C. Jaenicke (Eds.). Medpharm GmbH Scientific Publishers, Stuttgart Germany (2003)
839
Herbal Remedies Connected to Malaria like Fever in Iranian Ancient Medicinal Books- Brief Review Article.
840
Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis
841
Herbal Remedies for Acne Vulgaris from the Viewpoint of Persian Medicine
842
Herbal Remedies for Cancer based on Persian Medicine
843
Herbal Remedies for Functional Dyspepsia and Traditional Iranian Medicine Perspective
844
Herbal remedies for oligomenorrhea in Traditional Persian Medicine
845
Herbal remedies—how safe are they? A case report of polymorphic ventricular tachycardia/ventricular fibrillation induced by herbal medication used for obesity
846
Herbal Research: Gaps Affecting the Quality and Validity of Research Findings
847
HERBAL RMIDIES USED FOR GASTROINTESTINAL DISORDERS IN KAGHAN VALLEY, NWFP, PAKISTAN
848
Herbal self-medication use in patients with diabetes mellitus type 2
849
Herbal Supplement Use and Herb–drug Interactions among Patients with Kidney Disease
850
Herbal supplementation diets on hematology and innate immunity in goldfish against Aeromonas hydrophila
851
Herbal Therapy and Treatment of Worm Infections, Emphasizing Taenia solium
852
Herbal Therapy for Burn Wound Infections
853
Herbal therapy in Covid-19: A systematic review of medicinal plants effective against Covid-19
854
Herbal therapy in opioid withdrawal syndrome: A systematic review of randomized clinical trials
855
HERBAL TREATMENT FOR CARDIOVASCULAR DISEASE THE EVIDENCE BASED THERAPY
856
Herbal Treatment of Oligomenorrhea with Sesamum indicum L.: A Randomized Controlled Trial
857
Herbal treatment options for female fertility disorders: a systematic review of clinical trials
858
Herbal Treatments for Asthma, according to Avicenna
859
Herbal Treatments to Gain Weight as the Potential Cause of Portal Vein Thrombosis and Hepatic Damage: A Case Report
860
Herbal, Animal and Mineral Remedies in Burn Wound: a review of Persian Traditional Medicine literature
861
Herbal-caffeinated chewing gum, but not bubble gum, improves aspects of memory
862
Herbals in cardiovascular practice: Are physicians neglecting anything?
863
Herbarium images launched
864
Herbarium specimens demonstrate earlier flowering times in response to warming in Boston
865
Herb–drug interaction of Fucus vesiculosus extract and amiodarone in rats: A potential risk for reduced bioavailability of amiodarone in clinical practice
866
Herb-drug interactions
867
Herb-drug interactions
868
Herb–drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats
869
Herbert Blankenhorn in the Third Reich
870
Herbert Bower
871
Herbert D. Kelleher, Southwest Airlines, 2003 Bower Award for Business Leadership laureate
872
Herbert Holik (Ed.), Handbook of paper and board, Wiley-VCH, Weinheim, Germany, 2006 (xix+505, £105-00, ISBN: 3-527-30997-7)
873
Herbert Robbins and sequential analysis
874
Herbert screw fixation of capitellar fractures
875
Herbert Simon and behavioral economics
876
Herbert Simon and the concept of dispersed entrepreneurship
877
Herbert Simon. Artificial intelligence as a framework for understanding intuition
878
Herbicidal activity of allelopathic extracts of sorghum and some herbicides on wheat and accompanied weeds
879
Herbicidal activity of constituents isolated from Solanum elaeagnifolium (Solanaceae)
880
HERBICIDAL ACTIVITY OF Datura metel L. AGAINST Phalaris minor Retz
881
Herbicidal activity of eight isothiocyanates on Texas panicum (Panicum texanum), large crabgrass (Digitaria sanguinalis), and sicklepod (Sennaobtusifolia)
882
Herbicidal Activity of Mycelial and Cell Free Extracts of Fusarium oxysporum F.sp. Ciceris Against Rice Weed Cyperus Iria l
883
HERBICIDAL ACTIVITY OF SOME MEDICINAL PLANTS EXTRACTS AGAINST Parthenium hysterophorus L.
884
Herbicidal and antioxidant responses of transgenic rice overexpressing Myxococcus xanthus protoporphyrinogen oxidase
885
HERBICIDAL CONTROL OF Lantana camara
886
HERBICIDAL EFFECT OF FICUS BENGALENSIS AQUEOUS EXTRACT ON IPOMOEA PENTAPHYLLA
887
Herbicidal effects under field conditions of Ailanthus altissima bark extract, which contains ailanthone
888
Herbicidal ionic liquid with dual-function
889
Herbicidal potential of Azadirachta indica leaves extract against Achyranthes aspera and Senna occidentalis
890
Herbicidal, Insecticidal and Structure-Activity Relationship Studies on Pyranopyrazole and Oxinobispyrazole Derivatives
891
Herbicide accumulation and evolution in reservoir sediments Original Research Article
892
Herbicide and insect resistant elite transgenic rice
893
Herbicide and metabolite movement in different soils as studied by computer assisted microlysimeters
894
Herbicide and plant growth regulator analysis by capillary electrophoresis
895
Herbicide concentrations in the Mississippi River Basin—the importance of chloroacetanilide herbicide degradates
896
Herbicide contamination and dispersion pattern in lowland springs Original Research Article
897
Herbicide contamination and the potential impact to seagrass meadows in Hervey Bay, Queensland, Australia
898
HERBICIDE CONTAMINATION IN CARROT GROWN IN PUNJAB, PAKISTAN
899
Herbicide contamination of surficial groundwater in Northern Italy
900
Herbicide dissipation and dynamics modelling in three different tillage systems
901
Herbicide distribution in soils of a riparian forest and neighboring sugar cane field
902
Herbicide dose and incorporation depth in combination with 1,3- dichloropropene plus chloropicrin for Cyperus rotundus control in tomato and pepper
903
Herbicide drift can affect plant and arthropod communities
904
Herbicide effect on growth and seed production of Lolium multiflorum in Atlantic Canada
905
Herbicide effects on typha latifolia (Linneaus) germination and root and shoot development
906
Herbicide evaluation for the control of wild taro
907
Herbicide impact on Hormosira banksii gametes measured by fluorescence and germination bioassays
908
Herbicide Isoproturon-Specific Binding in the Freshwater Macrophyte Elodea densa-A Single-Cell Fluorescence Study
909
Herbicide loss in surface runoff from a pastoral hillslope in the Pukemanga catchment (New Zealand): Role of pre-event soil water content
910
Herbicide losses in runoff events from a field with a low slope: Role of a vegetative filter strip
911
Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants CoExpressing Human CYP1A1, CYP2B6, and CYP2C19
912
Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants Expressing Human CYP1A1
913
Herbicide Metabolism and Tolerance in the Transgenic Rice Plants Expressing Human CYP2C9 and CYP2C19
914
Herbicide Residues in Water Resources: A Scoping Review
915
Herbicide Resistance and Supersensitivity in Ala250 or Ala251 Mutants of the D1 Protein in Chlamydomonas reinhardtii,
916
Herbicide resistance dynamics in a spatially heterogeneous environment
917
HERBICIDE RESISTANCE IN ANNUAL RYEGRASS (Lolium rigidum Gaud.) POPULATIONS IN WHEAT FIELDS OF FIROOZABAD IRAN
918
Herbicide Retention in Soil as Affected by Sugarcane Mulch Residue
919
Herbicide risk assessment for non-target aquatic plants: sulfosulfuron - a case study
920
Herbicide safeners: uses, limitations, metabolism, and mechanisms of action
921
Herbicide Selectivity applied in post-emergence of Mulato II grass
922
Herbicide sensitivity of Echinochloa spp. accessions in Italian rice fields
923
Herbicide sorption, degradation, and leaching in three Swedish soils under long-term conventional and reduced tillage
924
Herbicide tolerance in maize is related to increased levels of glutathione and glutathione-associated enzymes
925
Herbicide toxicity of Halophila ovalis assessed by chlorophyll a fluorescence
926
Herbicide transport by surface runoff and herbicide retention in a filter strip — Rainfall and runoff simulation studies
927
Herbicide transport via surface runoff during intermittent artificial rainfall: A laboratory plot scale study
928
Herbicide/Pesticide Effects on Intestinal Epithelial Growth,
929
Herbicides affect fluorescence and electron transfer activity of spinach chloroplasts, thylakoid membranes and isolated Photosystem II
930
Herbicides and herbicide degradates in shallow groundwater and the Cedar River near a municipal well field, Cedar Rapids, Iowa
931
Herbicides and Herbicide Degradation Products in Upper Midwest Agricultural Streams during August BaseFlow Conditions
932
Herbicides and nitrogen in precipitation: progression from west to east and contribution to the Marne river (France)
933
HERBICIDES AND THEIR DOSES EFFECTS ON WILD ONION (Asphodelus tenuifolius Cav.) IN CHICKPEA
934
Herbicides and their mechanisms of action. Sheffield Biological Sciences, Volume 6. Edited by Andrew Cobb and Ralph Kirkwood. 2000.
935
Herbicides and Transformation Products in Surface Waters of the Midwestern United States
936
Herbicides for control of isoproturon-resistant Littleseed Canarygrass (Phalaris minor) in wheat
937
Herbicides for control of metsulfuron resistant toothed dock (Rumex dentatus)
938
Herbicides genotoxicity
939
Herbicides genotoxicity
940
Herbicides have negligible effects on ants and springtails in an Australian wheat field
941
Herbicides have negligible effects on ants and springtails in an Australian wheat field
942
Herbicides implicated as the cause of severe mangrove dieback in the Mackay region, NE Australia: consequences for marine plant habitats of the GBR World Heritage Area
943
HERBICIDES, THEIR APPLICATION TIMINGS AND DIFFERENT SOIL TEMPERATURE REGIMES AFFECT WEED INFESTATION IN WHEAT
944
Herbicides, weeds and endangered species: management of bitou bush (Chrysanthemoides monilifera ssp. rotundata) with glyphosate and impacts on the endangered shrub, Pimelea spicata Original Research Article
945
Herbicide-tolerant sugarcane (Saccharum officinarum L.) plants: an unconventional method of weed removal
946
Herbivore and pollinator responses to grassland management intensity along experimental changes in plant species richness
947
Herbivore diet selection in response to simulated variation in nutrient rewards and plant secondary compounds
948
Herbivore host choice and optimal bad motherhood
949
Herbivore species and density affect vegetation-structure patchiness in salt marshes
950
Herbivore-associated elicitors: FAC signaling and metabolism
951
Herbivore-associated elicitors: FAC signaling and metabolism
952
Herbivore-induced coexistence of competing plant species
953
Herbivore-Induced Defense Response in a Model Legume. Two-Spotted Spider Mites Induce Emission of (E)-(beta)Ocimene and Transcript Accumulation of (E)-(beta)-Ocimene Synthase in Lotus japonicus
954
Herbivores alter the fitness benefits of a plant–rhizobium mutualism
955
Herbivores Coprolites from Chehrabad Salt Mine of Zanjan, Iran (Sassanid Era, 224-651 AD) Reveals Eggs of Strongylidae and Anoplocephalidae Helminths
956
Herbivores enable plant survival under nutrient limited conditions in a model grazing system
957
Herbivores enable plant survival under nutrient limited conditions in a model grazing system
958
Herbivores, the Functional Diversity of Plants Species, and the Cycling of Nutrients in Ecosystems
959
Herbivorous and microbial grazing pathways of metazooplankton in the Senegal River Estuary (West Africa)
960
Herbivory alters competitive interactions between two invasive aquatic plants
961
Herbivory alters the expression of a mixed-mating system
962
Herbivory and seedling performance in a fragmented temperate forest of Chile
963
Herbivory at marginal populations: Consequences for maternal fitness and vegetative differentiation
964
Herbivory by the pine weevil (Hylobius abietis L.) and short-snouted weevils (Strophosoma melanogrammum Forst. and Otiorhynchus scaber L.) during the conversion of a wind-thrown Norway spruce forest into a mixedspecies plantation
965
Herbivory by the weevil, Strophosoma melanogrammum, causes severalfold increase in emission of monoterpenes from young Norway spruce (Picea abies)
966
HERBIVORY COULD UNLOCK MUTATIONS SEQUESTERED IN STRATIFIED SHOOT APICES OF GENETIC MOSAICS
967
Herbivory in a Mediterranean forest: browsing impact and plant compensation
968
Herbivory in early Tertiary Arctic forests
969
Herbivory on macro-algae affects colonization of beach-cast algal wrack by detritivores but not its decomposition
970
Herbivory passing the limits
971
Herbivory responsive C2H2 zinc finger transcription factor protein StZFP2 from potato
972
Herbivory, foliar survival and shoot growth in fragmented populations of Aristotelia chilensis
973
Herbivory, hunting, and long-term vegetation change in degraded savanna Review Article
974
Herbivory, induced resistance, and interplant signal transfer in Alnus glutinosa
975
Herbological and agrotechnological approaches to weeding plants in modern flax growing
976
Herbological and agrotechnological approaches to weeding plants in modern flax growing
977
Herbrand theorems in arbitrary institutions
978
Herbs and alternative therapies in the hypertension clinic
979
Herbs and Hazards Risk of Aristolochic Acid Nephropathy in Iran
980
Herbs and Herbal Supplements, a Novel Nutritional Approach in Animal Nutrition
981
Herbs and natural supplements in the prevention and treatment of delayed-onset muscle soreness
982
Herbs Boosting Immunity in Covid-19: An Overview
983
Herbs drying using a heat pump dryer
984
HERBS IN A SUSTAINABLE ANIMAL NUTRITION
985
Herbs with anti-lipid effects and their interactions with statins as a chemical anti- hyperlipidemia group drugs: A systematic review
986
Herbs, botanicals and teas: G. Mazza, B.D. Oomah (Eds.); Technomic Publishing Co., Lancaster, PA, 2000, xvii+416 pp, ISBN 1-56676-851-9 (£77.00)
987
HERBVI - a program for simulation of baryon and lepton number violating processes Original Research Article
988
Herceptin (trastuzamab) in advanced breast cancer
989
Herceptin: mechanisms of action and resistance
990
Herculaneum victims of the volcanic eruptions of Vesuvius in 79 AD
991
Hercule Poirot and Criminal Psychology: Crime and Detection in Selected Novels of Agatha Christie
992
Hercule Poirot and the unquiet brain
993
Hercules project: Contributing to the development of the hydrogen infrastructure
994
Hercynian Acid Magmatism and Related Mineralizations in Northern Portugal
995
Hercynian high-altitude phenomena in the French Massif Central: tectonic implications
996
Hercynian polyphase tectonics in the northeast French Massif Central: the closure of the Brévenne Devonian–Dinantian rift
997
Hercynian post-collisional A-type granites of the Kokshaal Range, Southern Tien Shan, Kyrgyzstan
998
Hercynian structure of the Axial Zone of the Pyrenees: the Aran Valley cross-section (Spain-France)
999
Hercynian tectonics in the Pyrenees: a new view based on structural observations around the Bassie`s granite pluton
1000
Hercynian tectono-thermal evolution associated with crustal extension and exhumation of the Lora del Río metamorphic core complex (Ossa-Morena zone, Iberian Massif, SW Spain)
